Flagship explainer
What drives ACADIA PHARMACEUTICALS INC’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $391M | FY2025 |
| |
| Income before tax | $139M | FY2025 |
|
| Operating income | $105M | FY2025 |
|
| $1.1B | FY2025 |
| |
| Ending assets | $1.6B | FY2025 |
|
| Beginning assets | $1.2B | FY2024 |
|
| $1.2B | FY2025 |
| |
| $733M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-072519